Quick answer In published celiac-disease research, larazotide acetate was most often given orally as 0.5 mg (500 mcg) three times daily before meals as an add-on to a continued gluten-free diet and that 0.5 mg dose, not higher doses, met the primary endpoint of a Phase 2b trial
But they have already made their mark in the field of diabetes and obesity
Cherney DZI, Hadjadj S, Lawson J, Mosenzon O, Tuttle K, Vrhnjak B, Rasmussen S, Bain SC
DOI: 10.1080/09546630701839312
In preclinical research environments, the individual components of GLOW Blend have been studied for their interaction with connective tissue-associated pathways, cellular communication mechanisms, cytoskeletal regulation, and copper-dependent biochemical signaling systems
GST plays roles in signal transduction pathways via interaction with signaling kinases such as JNK and Cdk2